newsfilter
← Latest News
GlobeNewswire·

Cyclerion Reports Corporate Update and Full Year 2022 Financial Results

CAMBRIDGE, Mass., March 22, 2023 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) today announced corporate updates including advances in its zagociguat (formerly CY6463) mitochondrial disease program.